Open Access

[Retracted] MicroRNA‑124‑3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1

  • Authors:
    • Ping Wang
    • Li Zhang
    • Junhui Zhang
    • Gangshu Xu
  • View Affiliations

  • Published online on: January 20, 2022     https://doi.org/10.3892/etm.2022.11157
  • Article Number: 233
  • Copyright : © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

March-2022
Volume 23 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang P, Zhang L, Zhang J and Xu G: [Retracted] MicroRNA‑124‑3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1. Exp Ther Med 23: 233, 2022.
APA
Wang, P., Zhang, L., Zhang, J., & Xu, G. (2022). [Retracted] MicroRNA‑124‑3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1. Experimental and Therapeutic Medicine, 23, 233. https://doi.org/10.3892/etm.2022.11157
MLA
Wang, P., Zhang, L., Zhang, J., Xu, G."[Retracted] MicroRNA‑124‑3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1". Experimental and Therapeutic Medicine 23.3 (2022): 233.
Chicago
Wang, P., Zhang, L., Zhang, J., Xu, G."[Retracted] MicroRNA‑124‑3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1". Experimental and Therapeutic Medicine 23, no. 3 (2022): 233. https://doi.org/10.3892/etm.2022.11157